GEODE CAPITAL MANAGEMENT, LLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 42 filers reported holding IMMUNOVANT INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$43,935,809
+97.9%
1,144,334
-2.2%
0.01%
+66.7%
Q2 2023$22,204,827
+36.5%
1,170,523
+11.6%
0.00%
+50.0%
Q1 2023$16,265,621
+91213.2%
1,048,718
+4.5%
0.00%0.0%
Q4 2022$17,813
-99.6%
1,003,595
+23.3%
0.00%
+100.0%
Q3 2022$4,540,000
+46.5%
813,669
+2.4%
0.00%
Q2 2022$3,100,000
-28.7%
794,972
+0.8%
0.00%
-100.0%
Q1 2022$4,346,000
-37.8%
788,838
-3.8%
0.00%0.0%
Q4 2021$6,989,000
-6.0%
820,399
-4.1%
0.00%0.0%
Q3 2021$7,437,000
-16.9%
855,908
+1.0%
0.00%0.0%
Q2 2021$8,953,000
-29.8%
847,110
+6.5%
0.00%
-50.0%
Q1 2021$12,756,000
-63.4%
795,320
+5.4%
0.00%
-66.7%
Q4 2020$34,849,000
+77.3%
754,490
+35.1%
0.01%
+50.0%
Q3 2020$19,652,000
+123.2%
558,481
+54.5%
0.00%
+100.0%
Q2 2020$8,804,000
+2854.4%
361,569
+1785.6%
0.00%
Q1 2020$298,00019,1750.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2020
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders